Business Context and Reporting Period
Company: Stepan Company (Stepan Co.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: Stepan produces intermediate chemicals used in consumer and industrial applications. Operations are divided into three segments: Surfactants (77% of sales), Polymers (20%), and Specialty Products (3%). The company operates globally with manufacturing sites in North America, Europe, Latin America, and Asia.
Key Financial Metrics
| Metric (in thousands) | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $422,598 | $337,030 |
| Gross Profit | $61,786 | $63,552 |
| Operating Income | $29,851 | $33,655 |
| Net Income (Attributable to Stepan) | $18,761 | $20,660 |
| Diluted EPS | $1.68 | $1.88 |
| Cash and Equivalents (End of Period) | $52,743 | $75,427 |
| Total Debt | $185,686 | $191,572 |
| Net Cash Used in Operating Activities | $(25,445) | $(3,312) |
Margins: Gross margin decreased to 14.6% in Q1 2011 from 18.9% in Q1 2010. Operating margin decreased to 7.1% from 10.0%.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 25% ($85.6 million) driven by higher average selling prices ($70.1 million), increased sales volume ($12.0 million), and favorable foreign currency translation ($3.5 million). Price increases were primarily due to rising raw material costs.
- Profit Decline: Despite revenue growth, Net Income declined 9% to $18.8 million. Operating income fell 11% ($3.8 million) due to a $1.8 million decrease in gross profit and a $2.0 million increase in operating expenses.
- Margin Compression: Gross profit declined due to rising raw material costs in Europe and the Specialty Products segment. Selling price increases did not fully offset cost inflation in all regions.
- Expense Increases: Administrative expenses rose 20% ($1.8 million), largely due to a $1.4 million decrease in deferred compensation income caused by a smaller decline in the company's stock price compared to the prior year.
- Cash Flow: Operating cash flow turned negative ($25.4 million used) compared to a smaller use in the prior year ($3.3 million). This was driven by a significant increase in working capital requirements: receivables increased by $63.9 million and inventories by $21.0 million, reflecting higher sales volumes and raw material costs.
Guidance, Outlook, and Risks
- Outlook: Management remains optimistic about volume growth and margin improvement for the remainder of 2011. The company has increased selling prices to address raw material costs.
- Surfactants: Earnings improvement expected from unit margin improvement, better sales mix, and volume growth in Brazil. Rising crude oil prices are expected to stimulate demand for enhanced oil recovery surfactants.
- Polymers: Demand exceeded expectations in Q1; further growth anticipated during the summer roof replacement season. A polyol capacity expansion in Germany is scheduled to start up in Q2 2011.
- Capital Expenditures: Full-year 2011 capital spending is estimated at $85 million to $90 million, excluding a $12.2 million warehouse purchase made in Q1.
- Risks and Contingencies:
- Environmental/Legal: The company faces potential liabilities for environmental remediation at various sites (e.g., Maywood NJ, D'Imperio NJ, Wilmington MA, Poland). The estimated range of possible losses is $10.1 million to $29.4 million, with an accrued liability of $15.9 million.
- Raw Material Costs: Operations are heavily influenced by crude oil and natural oil prices. Continued volatility could impact margins if price increases cannot be passed to customers.
- Debt Covenants: The company is subject to debt covenants regarding interest coverage, net worth, and capitalization ratios. Management believes it will remain in compliance throughout 2011.
Investor Verification Checklist
- Working Capital Trends: Verify the sustainability of the $85 million increase in receivables and $21 million increase in inventory. Confirm if these are driven by genuine volume growth or potential collection issues.
- Margin Recovery: Monitor the effectiveness of price increases in offsetting raw material costs, particularly in the European and Specialty Products segments where margins compressed significantly.
- Deferred Compensation Volatility: Note that administrative expenses are sensitive to the company's stock price due to deferred compensation accounting; verify future stock price impacts on reported earnings.
- Capital Project Execution: Track the timeline and cost of the Singapore methyl esters plant and Germany polyol expansion to ensure they meet the projected Q2/Q3 contribution to earnings.
- Environmental Reserves: Review updates on the Maywood and Poland remediation sites to ensure the $15.9 million accrued liability remains adequate against the $10.1M–$29.4M estimated loss range.